October 18, 2023, 12:00pm-1:30pm EST
COURSE DESCRIPTION
Xylazine is an emerging issue across the United States, often used in conjunction with opioids and other substances. Public health professionals must be aware of Xylazine’s effects and how it complicates efforts to prevent and treat other substance use. This presentation summarizes the available research and data on xylazine use.
LEARNING OBJECTIVES
PRESENTERS
Josh Esrick, MPP is the Chief of Training and Technical Assistance at Carnevale Associates, LLC. Mr. Esrick has over ten years of experience researching, writing, evaluating, and presenting on substance use prevention and other behavioral health topics. He is an expert in providing training and technical assistance (T/TA) in substance use, having overseen the development of hundreds of T/TA products for numerous clients, including six of SAMHSA’s ten regional Prevention Technology Transfer Centers (PTTCs), the PTTC Network Coordinating Office, the Central East Addiction Technology Transfer Center (ATTC) and Mental Health Technology Transfer Centers (MHTTC), and SAMHSA’s Center for the Application of Prevention Technologies (CAPT). These trainings and products have covered a wide range of topics, including strategic planning, data collection and analysis, and identifying evidence-based prevention interventions for youth. In addition to T/TA, Mr. Esrick has directly provided many of these services to behavioral health agencies and other entities. He has published several academic journal articles. He holds a Bachelor of Arts in Political Science from the State University of New York at Buffalo and a Master of Public Policy from George Washington University.
Emily Patton, MSc, PgDip holds a Masters of Science in Abnormal and Clinical Psychology from Swansea University and a Postgraduate Degree in Criminology and Criminal Justice from the University of Edinburgh. She offers significant professional experience in the fields of public policy development and analysis, criminal justice research, data collection and analysis, program development, and performance management.
Deborah Nixon-Hughes, LCSW-C, is the Project Director for the Central East Prevention Technology Transfer Center (PTTC). She is responsible to use proven technology transfer strategies and practices to promote the adoption and implementation of evidence-based prevention and early intervention approaches. Debbie will be the spokesperson and liaison to federal, regional, state and local entities; academic institutions; and prevention, treatment, and/or recovery agencies. Deborah is responsible to identify prevention needs through engaging and collaborating with primary care providers; individuals experiencing behavioral health challenges and their families; and other community stakeholders/systems. As a result, she recommends and coordinates workforce trainings and technical assistance initiatives that can address the needs identifies, and thus reduce the effect of mental and substance use disorders on the health of individuals, their families, and their communities.